226 related articles for article (PubMed ID: 10473967)
21. Effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas.
Peghini PL; Annibale B; Azzoni C; Milione M; Corleto VD; Gibril F; Venzon DJ; Delle Fave G; Bordi C; Jensen RT
Gastroenterology; 2002 Jul; 123(1):68-85. PubMed ID: 12105835
[TBL] [Abstract][Full Text] [Related]
22. Hyperplastic, dysplastic, and neoplastic enterochromaffin-like-cell proliferations of the gastric mucosa. Classification and histogenesis.
Solcia E; Fiocca R; Villani L; Luinetti O; Capella C
Am J Surg Pathol; 1995; 19 Suppl 1():S1-7. PubMed ID: 7762735
[TBL] [Abstract][Full Text] [Related]
23. Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome.
Feurle GE
Gut; 1994 Feb; 35(2):275-7. PubMed ID: 8307483
[TBL] [Abstract][Full Text] [Related]
24. Gastric endocrine cell proliferation and fundic argyrophil carcinoid tumors in patients with the Zollinger-Ellison syndrome.
Cadiot G; Lehy T; Mignon M
Acta Oncol; 1993; 32(2):135-40. PubMed ID: 8323754
[TBL] [Abstract][Full Text] [Related]
25. Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association.
Solcia E; Capella C; Fiocca R; Rindi G; Rosai J
Am J Surg Pathol; 1990 Jun; 14(6):503-13. PubMed ID: 1970928
[TBL] [Abstract][Full Text] [Related]
26. Hypergastrinemia and enterochromaffin-like cell hyperplasia.
Delle Fave G; Marignani M; Moretti A; D'Ambra G; Martino G; Annibale B
Yale J Biol Med; 1998; 71(3-4):291-301. PubMed ID: 10461360
[TBL] [Abstract][Full Text] [Related]
27. [Gastric carcinoid--pathogenesis and treatment].
Bründler R; Gebbers JO; Criblez D
Schweiz Med Wochenschr; 1999 Jun; 129(25):945-50. PubMed ID: 10422189
[TBL] [Abstract][Full Text] [Related]
28. Production of basic fibroblast growth factor by gastric carcinoid tumors and their putative cells of origin.
Bordi C; Falchetti A; Buffa R; Azzoni C; D'Adda T; Caruana P; Rindi G; Brandi ML
Hum Pathol; 1994 Feb; 25(2):175-80. PubMed ID: 8119718
[TBL] [Abstract][Full Text] [Related]
29. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.
Gilligan CJ; Lawton GP; Tang LH; West AB; Modlin IM
Am J Gastroenterol; 1995 Mar; 90(3):338-52. PubMed ID: 7872269
[TBL] [Abstract][Full Text] [Related]
30. Management of carcinoid tumors of the stomach, duodenum, and pancreas.
Akerström G
World J Surg; 1996 Feb; 20(2):173-82. PubMed ID: 8661814
[TBL] [Abstract][Full Text] [Related]
31. Vesicular monoamine transporter 2 as a marker of gastric enterochromaffin-like cell tumors.
Rindi G; Paolotti D; Fiocca R; Wiedenmann B; Henry JP; Solcia E
Virchows Arch; 2000 Mar; 436(3):217-23. PubMed ID: 10782879
[TBL] [Abstract][Full Text] [Related]
32. Carcinogenic hypergastrinemia: signet-ring cell carcinoma in a patient with multiple endocrine neoplasia type 1 with Zollinger-Ellison's syndrome.
Schott M; Sagert C; Willenberg HS; Schinner S; Ramp U; Varro A; Raffel A; Eisenberger C; Zacharowski K; Perren A; Scherbaum WA
J Clin Endocrinol Metab; 2007 Sep; 92(9):3378-82. PubMed ID: 17609302
[TBL] [Abstract][Full Text] [Related]
33. Beta-microseminoprotein in gastric carcinoids: a marker of tumour progression.
Weiber H; Borch K; Sundler F; Fernlund P
Digestion; 1999; 60(5):440-8. PubMed ID: 10473968
[TBL] [Abstract][Full Text] [Related]
34. Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas.
Bashir S; Gibril F; Ojeaburu JV; Asgharian B; Entsuah LK; Ferraro G; Crafa P; Bordi C; Jensen RT
Aliment Pharmacol Ther; 2002 Jul; 16(7):1367-82. PubMed ID: 12144588
[TBL] [Abstract][Full Text] [Related]
35. Progression of gastric enterochromaffin-like cells growth in Zollinger-Ellison syndrome and atrophic body gastritis patients.
Delle Fave G; Marignani M; Corleto VD; Angeletti S; D'Ambra G; Ferraro G; D'Adda T; Azzoni C; Jensen RT; Annibale B; Bordi C
Dig Liver Dis; 2002 Apr; 34(4):270-8. PubMed ID: 12038811
[TBL] [Abstract][Full Text] [Related]
36. One-year follow-up study of patients with enterochromaffin-like cell carcinoids after treatment with octreotide long-acting release.
Fykse V; Sandvik AK; Waldum HL
Scand J Gastroenterol; 2005 Nov; 40(11):1269-74. PubMed ID: 16334435
[TBL] [Abstract][Full Text] [Related]
37. Gastric carcinoids of argyrophil ECL cells.
Capella C; Polak JM; Timson CM; Frigerio B; Solcia E
Ultrastruct Pathol; 1980; 1(3):411-8. PubMed ID: 7233595
[TBL] [Abstract][Full Text] [Related]
38. Gastric masses in multiple endocrine neoplasia type I-associated Zollinger-Ellison syndrome.
von Rosenvinge EC; Wank SA; Lim RM
Gastroenterology; 2009 Oct; 137(4):1222, 537. PubMed ID: 19723598
[No Abstract] [Full Text] [Related]
39. Multiple gastric carcinoids and endocrine cell micronests in type A gastritis: Nuclear morphometric and immunohistochemical analysis.
Iwai K; Yao T; Nakamura S; Matsumoto T; Nishiyama K; Iida M; Tsuneyoshi M
Oncol Rep; 2005 Mar; 13(3):397-404. PubMed ID: 15706407
[TBL] [Abstract][Full Text] [Related]
40. Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship?
McCarthy DM
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
